Home
/
TELA Bio, Inc.
/
Financials
/
Quarterly
TELA Bio, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that TELA Bio, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$20.69M
Nov 14, 2025
Q2
2025
Jun 30, 2025
$20.20M
Aug 11, 2025
Q1
2025
Mar 31, 2025
$18.52M
May 8, 2025
Q3
2025
Sep 30, 2024
$18.96M
Nov 14, 2025
Q2
2025
Jun 30, 2024
$16.09M
Aug 11, 2025
Q1
2025
Mar 31, 2024
$16.60M
May 8, 2025
Q3
2024
Sep 30, 2023
$15.05M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$14.49M
Aug 13, 2024
Q1
2024
Mar 31, 2023
$11.91M
May 10, 2024
Q3
2023
Sep 30, 2022
$11.16M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$10.41M
Aug 10, 2023
Q1
2023
Mar 31, 2022
$8.23M
May 11, 2023
Q3
2022
Sep 30, 2021
$7.65M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$7.56M
Aug 11, 2022
Q1
2022
Mar 31, 2021
$5.88M
May 11, 2022
Q3
2021
Sep 30, 2020
$5.31M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$3.51M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$3.73M
May 14, 2021
Q3
2020
Sep 30, 2019
$3.97M
Nov 12, 2020
Q2
2020
Jun 30, 2019
$3.30M
Aug 13, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.60M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($9.92M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($11.26M)
May 8, 2025
Q3
2025
Sep 30, 2024
($10.37M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($12.60M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($5.66M)
May 8, 2025
Q3
2024
Sep 30, 2023
($10.96M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($10.79M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($12.03M)
May 10, 2024
Q3
2023
Sep 30, 2022
($10.71M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($12.74M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($10.86M)
May 11, 2023
Q3
2022
Sep 30, 2021
($8.27M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($8.26M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($8.14M)
May 11, 2022
Q3
2021
Sep 30, 2020
($7.70M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($6.08M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($7.22M)
May 14, 2021
Q3
2020
Sep 30, 2019
($4.67M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($5.26M)
Aug 13, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.55M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($9.08M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($10.47M)
May 8, 2025
Q3
2025
Sep 30, 2024
($9.37M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($11.57M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($4.83M)
May 8, 2025
Q3
2024
Sep 30, 2023
($10.18M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($10.36M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($11.25M)
May 10, 2024
Q3
2023
Sep 30, 2022
($9.49M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($10.24M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($9.84M)
May 11, 2023
Q3
2022
Sep 30, 2021
($7.22M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($7.31M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($7.27M)
May 11, 2022
Q3
2021
Sep 30, 2020
($6.86M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($5.17M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($6.50M)
May 14, 2021
Q3
2020
Sep 30, 2019
($3.86M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($4.30M)
Aug 13, 2020